Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

October 01, 1995; Volume 275,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 527;
  • You have access
    Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
    J L Wiley, J A Lowe, R L Balster and B R Martin
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 1-6;
  • You have access
    Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. I. The role of glutamate.
    G Lonart and K M Johnson
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 7-13;
  • You have access
    Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3',5'-guanosine monophosphate.
    G Lonart and K M Johnson
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 14-22;
  • You have access
    Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism.
    N Takeshita, Y Ohkubo and I Yamaguchi
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 23-30;
  • You have access
    Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
    A Wetterholm, J Z Haeggström, B Samuelsson, W Yuan, B Munoz and C H Wong
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 31-37;
  • You have access
    Effects of single and multiple intravenous cocaine injections in humans maintained on methadone.
    R W Foltin, I Christiansen, F R Levin and M W Fischman
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 38-47;
  • You have access
    Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin.
    L G Rochelle, S J Morana, H Kruszyna, M A Russell, D E Wilcox and R P Smith
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 48-52;
  • You have access
    Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
    R D Spealman
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 53-62;
  • You have access
    Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
    T L Yaksh, A B Malmberg, S Ro, P Schiller and M Goodman
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 63-72;
  • You have access
    Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.
    M Hirai, K Tanaka, T Shimizu, Y Tanigawara, M Yasuhara, R Hori, Y Kakehi, O Yoshida, K Ueda and T Komano
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 73-78;
  • You have access
    Phenethyl isothiocyanate, a new dietary liver aldehyde dehydrogenase inhibitor.
    K O Lindros, T Badger, M Ronis, M Ingelman-Sundberg and M Koivusalo
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 79-83;
  • You have access
    Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    C M Cahill, T D White and J Sawynok
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 84-93;
  • You have access
    Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
    Z Wang, G Ciabattoni, C Créminon, J Lawson, G A Fitzgerald, C Patrono and J Maclouf
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 94-100;
  • You have access
    Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    T F Seeger, P A Seymour, A W Schmidt, S H Zorn, D W Schulz, L A Lebel, S McLean, V Guanowsky, H R Howard and J A Lowe
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 101-113;
  • You have access
    Role of Na+ in the asymmetric paracellular transport of 4-phenylazobenzyloxycarbonyl-L-Pro-L-Leu-Gly-L-Pro-D-Arg across rabbit colonic segments and Caco-2 cell monolayers.
    W C Yen and V H Lee
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 114-119;
  • You have access
    Characterization of endothelin receptors mediating mechanical responses to the endothelins in the isolated stomach strip of the rat.
    G H Allcock, B Battistini, A Fournier, T D Warner and J R Vane
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 120-126;
  • You have access
    Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    P S Pagel, C P Harkin, D A Hettrick and D C Warltier
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 127-135;
  • You have access
    Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    H N Doods, W Wienen, M Entzeroth, K Rudolf, W Eberlein, W Engel and H A Wieland
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 136-142;
  • You have access
    Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
    H A Wieland, K D Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and H N Doods
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 143-149;
  • You have access
    Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
    C A Heidbreder, D Babovic-Vuksanovic, M Shoaib and T S Shippenberg
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 150-163;
  • You have access
    Schedule-controlled behavioral effects of the selective 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid antagonist LY293558 in pigeons.
    M J Benvenga, P L Ornstein and J D Leander
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 164-170;
  • You have access
    New antiinflammatory compounds that inhibit tumor necrosis factor production: probable interaction with protein kinase C activation.
    F Lang, J M Robert, P Boucrot, L Welin and J Y Petit
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 171-176;
  • You have access
    Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy.
    Y Imamura and G J Bennett
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 177-182;
  • You have access
    Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
    C A Sannerud and N A Ator
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 183-193;
  • You have access
    Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.
    T Aizawa, N Taguchi, Y Sato, T Nakabayashi, H Kobuchi, H Hidaka, T Nagasawa, F Ishihara, N Itoh and K Hashizume
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 194-199;
  • You have access
    Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.
    M Gellai, M Jugus, T Fletcher, P Nambi, E H Ohlstein, J D Elliott and D P Brooks
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 200-206;
  • You have access
    Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
    T Hayashi, A Kagaya, M Takebayashi, M Shimizu, Y Uchitomi, N Motohashi and S Yamawaki
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 207-214;
  • You have access
    The endothelin receptor profile in L6 myotubes.
    Z Fekete, X Y Yang, M Kimura and A Aviv
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 215-218;
  • You have access
    Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model.
    D M Dirig and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 219-227;
  • You have access
    Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
    G Cuadra and E Giacobini
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 228-236;
  • You have access
    Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    M A Hossain and N Weiner
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 237-244;
  • You have access
    Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
    R A Mathôt, J M Gubbens-Stibbe, W Soudijn, K A Jacobson, A P Ijzerman and M Danhof
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 245-253;
  • You have access
    Acute amiodarone terminates ventricular fibrillation by modifying cellular Ca++ homeostasis in isolated perfused rat hearts.
    S Kojima, S T Wu, J Wikman-Coffelt and W W Parmley
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 254-262;
  • You have access
    Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    W F Seidel, M Maze, W C Dement and D M Edgar
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 263-273;
  • You have access
    Microinjection of baclofen in the ventromedial medulla of rats: antinociception at low doses and hyperalgesia at high doses.
    D A Thomas, M K McGowan and D L Hammond
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 274-284;
  • You have access
    Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    J T Lin, D H Coy, S A Mantey and R T Jensen
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 285-295;
  • You have access
    Hepatic transport of rose bengal by perfused rabbit liver: the effect of albumin binding on the unidirectional rate constants.
    B A Luxon and P D King
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 296-305;
  • You have access
    Interactions of nifedipine with the renovascular effects of endothelin in humans.
    K A Kaasjager, H J van Rijn, H A Koomans and T J Rabelink
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 306-311;
  • You have access
    Leukotriene C4 receptors on guinea pig tracheocytes.
    S Prié, G Guillemette, G Boulay, P Borgeat and P Sirois
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 312-318;
  • You have access
    Arachidonic acid cascade and stimulation of acetylcholine release by human recombinant interleukin-1 beta in guinea pig ileum.
    S Mameya, T Sawa and K Taniyama
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 319-324;
  • You have access
    Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.
    H W Broening, J F Bowyer and W Slikker
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 325-333;
  • You have access
    Opioid modulation of fetal glucose homeostasis: role of receptor subtypes.
    H H Szeto, Y Soong, D L Wu and P Y Cheng
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 334-339;
  • You have access
    Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
    C D Kim and K W Hong
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 340-344;
  • You have access
    Cocaine sensitization in periadolescent and adult rats.
    G Laviola, R D Wood, C Kuhn, R Francis and L P Spear
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 345-357;
  • You have access
    Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study.
    M Volonté, A Ceci and F Borsini
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 358-367;
  • You have access
    Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    B S Tsai, R H Keith, W E Perkins, R E Walsh, C P Anglin, P W Collins, A W Gasiecki, R F Bauer, P H Jones and T S Gaginella
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 368-373;
  • You have access
    Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
    E R Butelman, C P France and J H Woods
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 374-380;
  • You have access
    Microinfusion of mu but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats.
    F J Helmstetter, P S Bellgowan and L H Poore
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 381-388;
  • You have access
    Actions of the benzopyran compound terikalant on macroscopic currents in rat ventricular myocytes.
    J G McLarnon and R Xu
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 389-396;
  • You have access
    Time- and concentration-dependent biphasic effect of ochratoxin A on growth of proximal tubular cells in primary culture.
    M Gekle, C A Pollock and S Silbernagl
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 397-404;
  • You have access
    Comparison of benzodiazepine receptor ligands with partial agonistic, antagonistic or partial inverse agonistic properties in precipitating withdrawal in squirrel monkeys.
    J R Martin, F Jenck and J L Moreau
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 405-411;
  • You have access
    Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.
    D K Pitts, L Wang, M D Kelland, A S Freeman and L A Chiodo
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 412-421;
  • You have access
    Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
    A Rubino and G Burnstock
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 422-428;
  • You have access
    Necessity of newly synthesized ATP by creatine kinase for contraction of permeabilized longitudinal muscle preparations of rat proximal colon.
    T Takeuchi, A Fujita, T Ishii, H Nishio and F Hata
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 429-434;
  • You have access
    Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.
    T A Aasmundstad, J Mørland and R E Paulsen
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 435-441;
  • You have access
    Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats.
    E Fernández, A I Galán, D Morán, J M González-Buitrago, M E Muñoz and R Jiménez
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 442-449;
  • You have access
    TEI-3313, a novel prostaglandin A1 derivative, prevents bone loss and enhances bone formation in immobilized male rats.
    T Ohta, Y Azuma, H Kanatani, M Kiyoki and Y Koshihara
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 450-455;
  • You have access
    Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in rats.
    S Kusstatscher, Z Sandor, S Szabo, A Seddon and P Böhlen
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 456-461;
  • You have access
    In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides.
    R M Crooke, M J Graham, M E Cooke and S T Crooke
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 462-473;
  • You have access
    Prevention and reduction of neural damage in ischemic strokes by w-(N,N'-diethylamino)-n-alkyl-3,4,5-trimethoxybenzoate compounds.
    G C Chiou and S J Hong
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 474-478;
  • You have access
    Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.
    T L Hartsell, J C Yalowich, M K Ritke, A J Martinez and N F Schor
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 479-485;
  • You have access
    Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat.
    A Rodríguez-Membrilla, V Martínez and P Vergara
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 486-493;
  • You have access
    Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.
    M Kinoshita, E Kume and H Tamaki
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 494-501;
  • You have access
    5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals.
    P A Pierce, G X Xie, S J Peroutka, P G Green and J D Levine
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 502-508;
  • You have access
    Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content.
    J Chen and M M Rasenick
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 509-517;
  • You have access
    Distribution of the mu and delta opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats.
    J P de Waele, K Kiianmaa and C Gianoulakis
    Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 518-527;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 275, Issue 1
1 Oct 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics